The results demonstrated that the Hsp90/PI3K dual inhibitor efficiently induced melanoma cell apoptotic death by interfering with the Hsp90-EGFR interaction and suppressed the downstream MAPK signaling pathways. Here, EGFR is linked to melanoma.